Target intelligence / Profile preview

Serine hydroxymethyltransferase 1 pseudogene 1 (SHMT1P1)

Target
SHMT1P1
Molecular classification
Pseudogene
01

Overview

SHMT1P1 (SHMT-ps1) is a processed pseudogene originating from the cytosolic serine hydroxymethyltransferase 1 gene (SHMT1). It is located on the short arm of chromosome 1 and exists specifically in the primate order, having arisen via reverse transcription after the divergence of primates from other mammals. SHMT1P1 contains unique sequence features—such as deletions, insertions, and single-base mutations—used to track primate phylogenetics and molecular lineage. Unlike its functional parent gene, SHMT1, SHMT1P1 does not encode an active protein or contribute to metabolic processes, disease mechanisms, or serve as a therapeutic target[2][1][3][5].

Other names
SHMT1 pseudogene 1SHMT-ps1SHMT1P1
02

Mechanism of action

Not applicable; as a non-functioning pseudogene, there is no mechanism of action relevant to pharmacology.

03

Biological functions

As a pseudogene, SHMT1P1 does not have an encoded protein or direct enzymatic or signaling function.Used as a genetic marker in phylogenetic studies of primates.
04

Disease associations

Not directly involved in disease biology, pathogenesis, or therapeutic intervention.Serves as a molecular marker for primate lineage studies.
05

Safety considerations

None reported or relevant; SHMT1P1 does not encode a product and has no direct physiological impact.
06

Interacting drugs

None reported; as a pseudogene, it does not interact with drugs directly.
07

Biomarkers

Used as a genetic marker in molecular evolutionary biology studies to distinguish primate lineages.

Beyond the preview

Go deeper on Serine hydroxymethyltransferase 1 pseudogene 1 (SHMT1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine hydroxymethyltransferase 1 pseudogene 1 (SHMT1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call